Decrease in blood histamine in drug-treated Parkinsonian patients

M. H. Coelho; I. J. Silva; M. S. Azevedo; C. F. Manso

doi:10.1007/bf03159928

journal article Apr 01, 1991

Decrease in blood histamine in drug-treated Parkinsonian patients

M. H. Coelho I. J. Silva M. S. Azevedo C. F. Manso

Molecular and Chemical Neuropathology Vol. 14 No. 2 pp. 77-85 · Springer Science and Business Media LLC

View at Publisher Save 10.1007/bf03159928

Topics

No keywords indexed for this article. Browse by subject →

References

24

[1]

Blanco I., Ferrer I., Toledo A., Sarria J., Picatoste F., Rodriguez R., Brandner R., Rodriguez J., and Sentis M. (1987) Subcellular localization of brain mast cell histamine in developing rat.Neuroch. Int. 11, 451–461. 10.1016/0197-0186(87)90035-0

[2]

Campos A. (1988) A possible crossed histamine-containing pathway adjacent to the sympathetic system of the rat vas deferens.J. Pharmacol. Exp. Therap. 244, 1121–1127. 10.1016/s0022-3565(25)24570-0

[3]

Cerone G., Ruggiere S., and Agnoli A., (1977) Parkinsonian tremor: A neuropharmacological study.Acta Neurol. 77, 213–229.

[4]

Cumming P., Kakubovic A., and Vincent S. R. (1989) Cerebral histamine levels are unaffected by MPTP administration in the mouse.Eur. J. Pharmacol. 166, 299–301. 10.1016/0014-2999(89)90071-x

[5]

Desiderio M. A., Zini I., Davalli P., Zoli M., Corti A., Fuxe K., and Agnati L. F. (1988) Polyamines, ornithine decarboxylase and diamine oxidase in the substantia nigra and striatum of the male rats after hemitranssection.J. Neural Trans. 51, 25–31.

[6]

Fantozzi R., Masini E., Blandina P., and Mannaione P. F. (1979) Cholinergic histamine release. Evidence of muscarinic receptors in rat mast cells.Agents and Actions, 57–58. 10.1007/bf02024110

[7]

Fantozzi R., Masini E., Blandina P., Mannaione P. F., and Banisachi T. (1978) Release of histamine from rat mast cells by acetylcholine.Nature 273, 473–474. 10.1038/273473a0

[8]

Garbard M., Barbin G., Feger J., and Schwartz J. C. (1974) Histaminergic pathway in rat brain evidenced by lesions of medial forebrain bundle.Science 186, 833–835. 10.1126/science.186.4166.833

[9]

Garbard M., Javoy-Agyd F., Schwartz J. C., and Agyd Y. (1983) Brain histidine decarboxylase activity in Parkinson disease.Lancet 1, 74–75. 10.1016/s0140-6736(83)91613-6

[10]

Gibberd F. B. (1986) The management of Parkinson disease.The Practitioner 230, 139–146.

[11]

Gordon G. R. and Peters J. H. (1967) Plasma histamine activity in various mammalian species. A rapid method of assay.Proc. Soc. Exp. Biol. Med. 124, 399–403. 10.3181/00379727-124-31750

[12]

Huff J. A., Davis V. E., and Brown H. (1966) A simplified technic for the estimation of histamine in blood and urine.J. Lab. Clin. Med. 67, 1044–1047.

[13]

Jones D. G., Turbull M. J., Lenman J. A. R., and Robertson M. A. H. (1972) Effect of amantadine on the urinary excretion of some monoamines and metabolites on normal and Parkinsonian subjects.J. Neurol. Sc. 17, 245–253. 10.1016/0022-510x(72)90030-5

[14]

Kahlson G. and Rosengren E. (1968) New approaches to the physiology of histamine.Phys. Rev. 48, 155–196.

[15]

Kapeller-Adler R. (1956) Is histamine identical with diamine oxidase?, inHistamine. Ciba Foundation Symposium (G. E. W. Wolstenholme and Celia M. O’Connor, eds), pp. 356–380, J. & Churchill, London. 10.1002/9780470718957.ch41

[16]

Lenman J. A. R., Turnbull M. J., Reid A., and Fleming A. M. (1977) Urinary monoamine metabolite excretion in disorders of movement.J. Neurol. Sci. 32, 219–235. 10.1016/0022-510x(77)90237-4

[17]

Nowak, J. Z. and Maslinski Cz (1977) Cholinergic link in the histamine-mediated increase in homovanillic acid in the rat.Agents and Actions 7, 27–30. 10.1007/bf01964877

[18]

Orr E. and Quay W. (1975) Hypothalamic 24 hour rhythms in histamine, histidine decarboxylase and histamine N-methyl-transferase.Endocrinology 96, 941–945. 10.1210/endo-96-4-941

[19]

Pfeiffer C. C., Iliev V., Goldstein L., Jennev E. H., and Schwartz R. (1970) Blood histamine, polyamines and the schizophrenias. Computer correlations of the low and high blood histamine types.Res. Commun. Chem. Pathol. and Pharmacol. 1, 247–265.

[20]

Phillis J., Tebeais A., and York D. (1968) Histamine and some antihistamines: Their actions on cerebral cortical neurones.Br. J. Pharmacol. Chemother. 33, 426–440. 10.1111/j.1476-5381.1968.tb00492.x

[21]

Quinn N. (1984) Antiparkinsonian drugs today.Drugs 28, 236–264. 10.2165/00003495-198428030-00002

[22]

Schwartz J. C. (1977) Histaminergic mechanisms in brain.Ann. Rev. Pharmacol. Toxicol 13, 325–339. 10.1146/annurev.pa.17.040177.001545

[23]

Schwartz J. C., Pollard H., Bischoff S., Rehault M. C., and Verdiere-Sahugue M. (1971) Catabolism of histamine in the rat brain after intracisternal administration.Europ. J. Pharmacol. 16, 326–335. 10.1016/0014-2999(71)90035-5

[24]

Sharpless N., Muenter M., and Tyce G. (1975) Effect ofl-dopa on endogenous histamine metabolism.Med. Biol. 53, 85–92.

Metrics

29

Citations

24

References

Details

Published: Apr 01, 1991
Vol/Issue: 14(2)
Pages: 77-85
License: View

Authors

Research Group Separations by Adsorption (GPSA), Department of Chemical Engineering, Technology Center, Federal University of Ceará, Fortaleza, Ceará, Brazil

Cite This Article

M. H. Coelho, I. J. Silva, M. S. Azevedo, et al. (1991). Decrease in blood histamine in drug-treated Parkinsonian patients. Molecular and Chemical Neuropathology, 14(2), 77-85. https://doi.org/10.1007/bf03159928

Decrease in blood histamine in drug-treated Parkinsonian patients

You May Also Like